These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14513812)

  • 1. [Effect of surfactants on the in vitro and in vivo properties of amphotericin B liposome].
    Zhang XB; Xie JQ; Hou XP
    Yao Xue Xue Bao; 2003 Jun; 38(6):471-4. PubMed ID: 14513812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic efficiency of amphotericin B liposome modified by RMP-7 to transport drug across blood brain barrier].
    Zhang XB; Yuan S; Lei PC; Hou XP
    Yao Xue Xue Bao; 2004 Apr; 39(4):292-5. PubMed ID: 15303662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The study on brain targeting of the amphotericin B liposomes.
    Zhang X; Xie J; Li S; Wang X; Hou X
    J Drug Target; 2003 Feb; 11(2):117-22. PubMed ID: 12881198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of amphotericin B magnetic liposomes for brain targeting.
    Zhao M; Hu J; Zhang L; Zhang L; Sun Y; Ma N; Chen X; Gao Z
    Int J Pharm; 2014 Nov; 475(1-2):9-16. PubMed ID: 25151436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysorbate Surfactants as Drug Carriers: Tween 20-Amphotericin B Conjugates as Anti-Fungal and Anti-Leishmanial Agents.
    Ravichandran V; Kesavan V; Cojean S; Loiseau PM; Jayakrishnan A
    Curr Drug Deliv; 2018; 15(7):1028-1037. PubMed ID: 29732967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascorbyl dipalmitate/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs.
    Moribe K; Maruyama S; Inoue Y; Suzuki T; Fukami T; Tomono K; Higashi K; Tozuka Y; Yamamoto K
    Int J Pharm; 2010 Mar; 387(1-2):236-43. PubMed ID: 20005934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
    Alvarez C; Shin DH; Kwon GS
    Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and distribution of superoxide dismutase liposomes in rats].
    Zhang YL; Xie Y; Wang HJ; Hou XP; Liu Y
    Yao Xue Xue Bao; 2005 Feb; 40(2):173-7. PubMed ID: 15875677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
    Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
    J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
    Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
    Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of RMP-7 and its derivatives on the transportation of liposome into the brain].
    Zhang XB; Jin YG; Xie Y; Xu K; Hou XP
    Yao Xue Xue Bao; 2003 Nov; 38(11):867-70. PubMed ID: 14992004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced encapsulation of amphotericin B into liposomes by complex formation with polyethylene glycol derivatives.
    Moribe K; Tanaka E; Maruyama K; Iwatsuru M
    Pharm Res; 1998 Nov; 15(11):1737-42. PubMed ID: 9833996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic and antifungal activity of liposome-entrapped amphotericin B prepared by the precipitation method.
    Kim JC; Lee EO; Kim JY; Bae SK; Choi TB; Kim JD
    Pharm Dev Technol; 1997 Aug; 2(3):275-84. PubMed ID: 9552455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical design of the liposomal antimicrobial agents for infectious disease.
    Moribe K; Maruyama K
    Curr Pharm Des; 2002; 8(6):441-54. PubMed ID: 12069381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and transdermal absorption of topical amphotericin B liposome formulations.
    Manosroi A; Kongkaneramit L; Manosroi J
    Int J Pharm; 2004 Feb; 270(1-2):279-86. PubMed ID: 14726142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of aerosolized liposomal amphotericin B.
    Lambros MP; Bourne DW; Abbas SA; Johnson DL
    J Pharm Sci; 1997 Sep; 86(9):1066-9. PubMed ID: 9294824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ liposomal preparation containing amphotericin B: related toxicity and tissue disposition studies.
    Chakraborty KK; Naik SR
    Pharm Dev Technol; 2000; 5(4):543-53. PubMed ID: 11109253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles.
    Ren T; Xu N; Cao C; Yuan W; Yu X; Chen J; Ren J
    J Biomater Sci Polym Ed; 2009; 20(10):1369-80. PubMed ID: 19622277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of RMP-7 and its derivative on transporting Evans blue liposomes into the brain.
    Zhang X; Xie Y; Jin Y; Hou X; Ye L; Lou J
    Drug Deliv; 2004; 11(5):301-9. PubMed ID: 15742555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.